Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Microbiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies.

Rupp C, Bode K, Weiss KH, Rudolph G, Bergemann J, Kloeters-Plachky P, Chahoud F, Stremmel W, Gotthardt DN, Sauer P.

Medicine (Baltimore). 2016 Mar;95(10):e2390. doi: 10.1097/MD.0000000000002390.

2.

Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis.

Voigtländer T, Leuchs E, Vonberg RP, Solbach P, Manns MP, Suerbaum S, Lankisch TO.

J Infect. 2015 May;70(5):483-90. doi: 10.1016/j.jinf.2015.01.013. Epub 2015 Feb 7.

PMID:
25659761
3.

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis.

Rupp C, Bode KA, Chahoud F, Wannhoff A, Friedrich K, Weiss KH, Sauer P, Stremmel W, Gotthardt DN.

BMC Infect Dis. 2014 Oct 23;14:562. doi: 10.1186/s12879-014-0562-8.

4.

Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis.

Lenz P, Eckelskemper F, Erichsen T, Lankisch T, Dechêne A, Lubritz G, Lenze F, Beyna T, Ullerich H, Schmedt A, Domagk D.

World J Gastroenterol. 2014 Sep 14;20(34):12260-8. doi: 10.3748/wjg.v20.i34.12260.

5.

Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.

Rupp C, Friedrich K, Folseraas T, Wannhoff A, Bode KA, Weiss KH, Schirmacher P, Sauer P, Stremmel W, Gotthardt DN.

Aliment Pharmacol Ther. 2014 Apr;39(8):873-82. doi: 10.1111/apt.12663. Epub 2014 Feb 24.

6.

Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis.

Katt J, Schwinge D, Schoknecht T, Quaas A, Sobottka I, Burandt E, Becker C, Neurath MF, Lohse AW, Herkel J, Schramm C.

Hepatology. 2013 Sep;58(3):1084-93. doi: 10.1002/hep.26447. Epub 2013 Jul 30.

PMID:
23564624
7.

The risk factors of fungal infection in living-donor liver transplantations.

Ohkubo T, Sugawara Y, Takayama T, Kokudo N, Makuuchi M.

J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):382-8. doi: 10.1007/s00534-011-0423-4.

PMID:
21792556
8.

Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation.

Kirchner GI, Scherer MN, Obed A, Ruemmele P, Wiest R, Froh M, Loss M, Schlitt HJ, Schölmerich J, Gelbmann CM.

Scand J Gastroenterol. 2011 Apr;46(4):471-8. doi: 10.3109/00365521.2010.537683. Epub 2010 Nov 30.

PMID:
21114429
9.

Sclerosing cholangitis associated with good syndrome.

Kampitak T, Putiworanat P, Chantaphakul H, Klaewsongkram J.

J Investig Allergol Clin Immunol. 2009;19(6):509-10. No abstract available.

10.

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis.

Rudolph G, Gotthardt D, Klöters-Plachky P, Kulaksiz H, Rost D, Stiehl A.

J Hepatol. 2009 Jul;51(1):149-55. doi: 10.1016/j.jhep.2009.01.023. Epub 2009 Mar 27.

PMID:
19410324
11.

[Fungal liver abscesses in a patient with primary sclerosing cholangitis and Crohn's disease].

Melero JL, Bastida G, Yago M, Nevárez A, Nos P, Ponce J.

Gastroenterol Hepatol. 2008 Nov;31(9):576-9. Spanish.

PMID:
19091246
12.

[Liver transplantation with a living donor: the first 3 cases in Rotterdam].

Kazemier G, Metselaar HJ, de Man RA, Tran TC, Groenland TH, Tilanus HW.

Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):817-21. Dutch.

PMID:
18491825
13.

Biliary candida infections in primary sclerosing cholangitis.

Kulaksiz H, Rudolph G, Kloeters-Plachky P, Sauer P, Geiss H, Stiehl A.

J Hepatol. 2006 Nov;45(5):711-6. Epub 2006 Aug 10.

PMID:
16979779
14.

The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.

Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME.

Medicine (Baltimore). 2003 Nov;82(6):373-84.

15.

Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population.

Molmenti EP, Squires RH, Nagata D, Roden JS, Molmenti H, Fasola CG, Prestidge C, D'Amico L, Casey D, Sanchez EQ, Goldstein RM, Levy MF, Benser M, McPhail W, Andrews W, Andersen JA, Klintmalm GB.

Pediatr Transplant. 2003 Apr;7(2):93-7.

PMID:
12654048
16.

Common bile duct obstruction due to candidiasis.

Domagk D, Bisping G, Poremba C, Fegeler W, Domschke W, Menzel J.

Scand J Gastroenterol. 2001 Apr;36(4):444-6.

PMID:
11336173
17.

Pancreatic ductal changes in HIV-infected patients.

Barthet M, Chauveau E, Bonnet E, Petit N, Bernard JP, Gastaut JA, Sahel J.

Gastrointest Endosc. 1997 Jan;45(1):59-63.

PMID:
9013171
18.

Pancreatic disease in AIDS--a review.

Cappell MS, Hassan T.

J Clin Gastroenterol. 1993 Oct;17(3):254-63. Review.

PMID:
8228089
19.

[Sclerosing cholangitis and AIDS].

Ramos C, Arazo P, Aguirre JM, Alvarez G, Aísa ML, Gonzalo C, Ferreria V.

Rev Clin Esp. 1992 Feb;190(2):79-81. Spanish.

PMID:
1561443

Supplemental Content

Loading ...
Support Center